Continuing Medical Education (CME) Credits
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors are not eligible for CME credits.
Target Audience
Anterior segment specialists, comprehensive ophthalmologists, residents, fellows, practice implementors.
Educational Objectives
Upon completion of this program, participants should be able to:
- Compare refractive IOLs and provide practical pearls and pitfalls for implanting different refractive IOLs.
- Examine refractive lens exchange and discuss selecting patients and determining the best individual refractive IOL choice.
- Outline how to establish or enhance a refractive IOL practice and how to improve communication efficacy.
- Employ tips for office and organization workflow that are specific to the evaluation and counseling of a refractive IOL patient.
- Discuss management of an unhappy refractive IOL patient and refractive or surgical complications.
- Recognize when to consider a refractive enhancement.
- Compare and contrast refractive enhancement options: Lasik, PRK, Piggyback lenses, LRI’s at the slit lamp, utilizing a femtosecond laser and YAG timing.
- Employ strategies for lens exchange techniques and/or how to enhance a lens.
Notice About Off-Label Use Presentations
The educational program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.
Claim CME/CE Credits
Attendees will receive a post event survey and CME credit claim on Monday, September 30, 2024 via email. Please contact cme@ascrs.org with any questions on credit claims.